|
/PRAvenueNW/ -- The Obama Administration and the Environmental Protection Agency (EPA) announced on February 3 final revisions to the National Renewable Fuel Standard program (RFS) for 2010 and beyond. The announcement affirms the important role biofuels play in creating new jobs, growing the economy, diversifying energy needs and reducing greenhouse gas emissions.
The actions outlined by the President’s Biofuels Interagency Working Group will ensure that the U.S. will meet the RFS goal of 36 billion gallons of biofuel production by 2022 of which 21 billion gallons will be advanced biofuels.
Steen Riisgaard, CEO of Novozymes, a world leader in bioinnovation: “The new commitment made by President Obama will significantly help grow and advance development of biofuels in the US and at the same time create thousands of new green jobs.”
Novozymes is at the forefront of developing key technologies that enables production of the biofuels fuelling cars today, as well as the advanced biofuels currently being commercialized. Novozymes recently announced that it will build a production facility in Nebraska to accommodate the growing market for biofuels.
Mr. Riisgaard: “The new RFS2 is a strong framework and by moving to E15 and increased accessibility of E85, the biofuel industry can create more long-lasting, high earning jobs that will help transform the way the U.S. and world use and consume fuel. And at the same time lessen US dependence on foreign oil.”
Novozymes recognizes that the 2007 Energy Bill requires a life cycle assessment of both direct and indirect greenhouse gas emissions from all fuels, including biofuels and including indirect land use change issues.
Mr. Riisgaard: “We commend the EPA for their significant work on this challenging issue. At the same time it is important to recognize that indirect land use change modeling is still in its infancy and lacks consensus in the scientific community. Moving forward, the U.S. government should act thoughtfully and deliberately and continue to study this issue.”
###
Media contacts:
Europe
Rene Tronborg
Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274
retr@novozymes.com Analyst and investor contacts:
Europe
Tobias Bjorklund
Tel. (direct): +45 4446 8682
Tel. (mobile): +45 3077 8682
tobb@novozymes.com
US
Paige Donnelly
Tel. (direct): +1 919 494 3209
Tel. (mobile): +1 919 218 4501
pagd@novozymes.com
US
Thomas Steenbech Bomhoff
Tel. (mobile): +1 919 649 2565
tsbm@novozymes.com
About Novozymes:
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow’s industrial biosolutions, improving our customers' business, and the use of our planet's resources.
With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace.
Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature’s potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces.
Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.
Novozymes is quoted on NASDAQ OMX Copenhagen A/S. Read more at www.novozymes.com.
|
